Published in Bull World Health Organ on May 01, 2007
Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev (2009) 1.87
Evidence-based tuberculosis diagnosis. PLoS Med (2008) 1.82
Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial. PLoS Med (2014) 1.49
Scale-up of multidrug-resistant tuberculosis laboratory services, Peru. Emerg Infect Dis (2008) 1.17
High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors. PLoS One (2011) 0.90
Atomic force microscopy fishing and mass spectrometry identification of gp120 on immobilized aptamers. Int J Nanomedicine (2014) 0.82
Immunocytochemistry versus nucleic acid amplification in fine needle aspirates and tissues of extrapulmonary tuberculosis. J Cytol (2012) 0.81
An innovative educational approach to professional development of medical laboratory scientists in Botswana. Adv Med Educ Pract (2014) 0.78
The dragon and the tiger: realties in the control of tuberculosis. Interdiscip Perspect Infect Dis (2012) 0.78
Decentralization of Acid Fast Bacilli(AFB) External Quality Assurance Using Blind Rechecking for Sputum Smear Microscopy in Ethiopia. PLoS One (2016) 0.76
Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis (2005) 12.59
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 9.35
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep (2006) 7.90
Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol (1993) 5.99
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 4.63
Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol (1993) 4.05
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis (2002) 2.79
Progress towards improved tuberculosis diagnostics for developing countries. Lancet (2006) 2.16
Chronic cough in primary health care attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection. Clin Infect Dis (2005) 2.06
'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis (2001) 1.92
Tuberculosis bacteriology--priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis (2005) 1.54
Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis (2003) 1.48
Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis (1998) 1.32
National plan for reliable tuberculosis laboratory services using a systems approach. Recommendations from CDC and the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. MMWR Recomm Rep (2005) 1.31
Evaluation of new external quality assessment guidelines involving random blinded rechecking of acid-fast bacilli smears in a pilot project setting in Mexico. Int J Tuberc Lung Dis (2005) 1.28
Recommended standards for modern tuberculosis laboratory services in Europe. Eur Respir J (2006) 1.27
Rapid HIV antibody testing in the New York State Anonymous HIV Counseling and Testing Program: experience from the field. J Acquir Immune Defic Syndr (2006) 1.24
Implementation of a quality systems approach for laboratory practice in resource-constrained countries. AIDS (2005) 1.18
A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures. Emerg Infect Dis (2002) 1.17
Quality assessment of sputum transportation, smear preparation and AFB microscopy in a rural district in Malawi. Int J Tuberc Lung Dis (2002) 1.16
Use of a standardised checklist to assess peripheral sputum smear microscopy laboratories for tuberculosis diagnosis in Uganda. Int J Tuberc Lung Dis (2002) 1.13
Under-diagnosis of smear-positive pulmonary tuberculosis in Nairobi, Kenya. Int J Tuberc Lung Dis (2001) 1.10
Quality control of smear microscopy for acid-fast bacilli: the case for blinded re-reading. Int J Tuberc Lung Dis (1999) 1.04
Quality assessment of smear microscopy for acid-fast bacilli in the Argentine tuberculosis laboratory network, 1983-2001. Int J Tuberc Lung Dis (2004) 0.95
Improving the laboratory diagnosis of TB in Ghana: the impact of a quality assurance system. Int J Tuberc Lung Dis (2006) 0.95
Expanding culture and drug susceptibility testing capacity in tuberculosis diagnostic services: the new challenge. Int J Tuberc Lung Dis (2007) 0.83
Will the bleach method keep its promise in sputum smear microscopy? Int J Tuberc Lung Dis (2005) 0.78
Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis. J Clin Microbiol (2003) 0.78
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet (2009) 7.22
Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis (2002) 3.89
IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber Lung Dis (1995) 3.76
Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis (2004) 2.64
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis (2009) 2.55
Rapid decline in prevalence of pulmonary tuberculosis after DOTS implementation in a rural area of South India. Int J Tuberc Lung Dis (2008) 2.43
Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis (2005) 2.41
Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis (2002) 2.30
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol (2001) 2.28
Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients. J Clin Microbiol (2004) 2.06
Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J Tuberc (2007) 2.04
Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol (1995) 1.95
Use of variable-number tandem-repeat typing to differentiate Mycobacterium tuberculosis Beijing family isolates from Hong Kong and comparison with IS6110 restriction fragment length polymorphism typing and spoligotyping. J Clin Microbiol (2005) 1.87
Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol Lett (2004) 1.86
Nutritional supplementation in HIV-infected individuals in South India: a prospective interventional study. Clin Infect Dis (2010) 1.78
Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med (2005) 1.69
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J Antimicrob Chemother (2005) 1.64
Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis (2008) 1.63
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol (2003) 1.62
Lack of association between presentation of diarrhoeal symptoms and faecal isolation of Aeromonas spp. amongst outpatients in Hong Kong. J Med Microbiol (2006) 1.52
Interferon gamma (IFNgamma) & interleukin-4 (IL-4) gene variants & cytokine levels in pulmonary tuberculosis. Indian J Med Res (2006) 1.50
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India. Clin Infect Dis (2008) 1.48
Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis (2006) 1.48
Impact of BCG vaccination on tuberculin surveys to estimate the annual risk of tuberculosis infection in south India. Indian J Med Res (2006) 1.47
Quinolone resistance determinant qnrA3 in clinical isolates of Salmonella in 2000-2005 in Hong Kong. J Antimicrob Chemother (2006) 1.40
A novel method of staining acid-fast bacilli in sputum containers. Indian J Med Res (2006) 1.39
Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India. Indian J Tuberc (2007) 1.38
Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. Infect Genet Evol (2007) 1.37
Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors. Indian J Med Res (2007) 1.36
Trend in the prevalence of TB infection and ARTI after implementation of a DOTS programme in south India. Int J Tuberc Lung Dis (2006) 1.36
Status of re-registered patients for tuberculosis treatment under DOTS programme. Indian J Tuberc (2007) 1.34
Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol (2006) 1.34
Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J Med Res (2006) 1.29
Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center. J Commun Dis (2006) 1.29
Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience. Indian J Tuberc (2007) 1.28
Selected biological and behavioural risk factors associated with pulmonary tuberculosis. Int J Tuberc Lung Dis (2007) 1.27
Evaluation of post-treatment health-related quality of life (HRQoL) among tuberculosis patients. Int J Tuberc Lung Dis (2007) 1.26
The prevalence of tuberculosis in different economic strata: a community survey from South India. Int J Tuberc Lung Dis (2007) 1.25
Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. Int J Tuberc Lung Dis (2003) 1.25
First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuberc Lung Dis (2010) 1.22
EDTA susceptibility leading to false detection of metallo-beta-lactamase in Pseudomonas aeruginosa by Etest and an imipenem-EDTA disk method. Int J Antimicrob Agents (2005) 1.22
Evaluation of the phenol ammonium sulfate sedimentation smear microscopy method for diagnosis of pulmonary tuberculosis. J Clin Microbiol (2002) 1.21
Application of lot sampling of sputum AFB smears for the assessment of microscopy centres. Int J Tuberc Lung Dis (2005) 1.20
Quality assurance studies in eight State tuberculosis laboratories in India. Int J Tuberc Lung Dis (2003) 1.19
Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber Lung Dis (1999) 1.18
Characterization of a Bacillus anthracis isolate causing a rare case of fatal anthrax in a 2-year-old boy from Hong Kong. J Clin Microbiol (2005) 1.16
Inefficiency of 0.3% carbol fuchsin in ziehl-neelsen staining for detecting acid-fast bacilli. J Clin Microbiol (2002) 1.16
A baseline survey of the prevalence of tuberculosis in a community in south India at the commencement of a DOTS programme. Int J Tuberc Lung Dis (2003) 1.16
Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2003) 1.15
Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. Int J Tuberc Lung Dis (2008) 1.15
Impact of advocacy on the tuberculosis management practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis (2009) 1.15
Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol (2004) 1.15
Evaluation of PCR using TRC(4) and IS6110 primers in detection of tuberculous meningitis. J Clin Microbiol (2001) 1.13
Suppressive activity of splenic adherent cells from Plasmodium chabaudi-infected mice. J Immunol (1980) 1.13
Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ (2006) 1.12
Evaluation of a two-reagent cold staining method for detection of acid-fast bacilli. Int J Tuberc Lung Dis (2002) 1.12
Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol (2005) 1.11
Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Exp Parasitol (1996) 1.10
Additional risk of developing TB for household members with a TB case at home at intake: a 15-year study. Int J Tuberc Lung Dis (2007) 1.10
Smear examination of two specimens for diagnosis of pulmonary tuberculosis in Tiruvallur District, south India. Int J Tuberc Lung Dis (2004) 1.10
Coincident filarial, intestinal helminth, and mycobacterial infection: helminths fail to influence tuberculin reactivity, but BCG influences hookworm prevalence. Am J Trop Med Hyg (2006) 1.08
Expression of the herpes simplex virus type 1 glycoprotein C gene requires sequences in the 5' noncoding region of the gene. J Virol (1990) 1.08
Yield of pulmonary tuberculosis cases by employing two screening methods in a community survey. Int J Tuberc Lung Dis (2006) 1.08
Relationship of ARTI to incidence and prevalence of tuberculosis in a district of south India. Int J Tuberc Lung Dis (2006) 1.08
Blinded rechecking of sputum smears for acid-fast bacilli to ensure the quality and usefulness of restaining smears to assess false-positive errors. Int J Tuberc Lung Dis (2003) 1.07
Lot quality assurance sampling of sputum acid-fast bacillus smears for assessing sputum smear microscopy centers. J Clin Microbiol (2005) 1.07
An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis. J Immunol (1987) 1.07
Reduced detection by Ziehl-Neelsen method of acid-fast bacilli in sputum samples preserved in cetylpyridinium chloride solution. Int J Tuberc Lung Dis (2004) 1.05
1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis. Cytokine (2007) 1.04
5' regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patients. J Clin Immunol (2008) 1.02
Specific and early detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis 38kDa antigen in pulmonary tuberculosis. Tuberculosis (Edinb) (2001) 1.01
Molecular epidemiology of tuberculosis in a rural area of high prevalence in South India: implications for disease control and prevention. J Clin Microbiol (2002) 1.00
The use of beta-galactosidase as a marker gene to define the regulatory sequences of the herpes simplex virus type 1 glycoprotein C gene in recombinant herpesviruses. Nucleic Acids Res (1988) 0.99
Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine (2008) 0.98
Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis. Cytokine (2008) 0.98
Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol (2013) 0.98
Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One (2013) 0.98
Simultaneous infection with multiple strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis (2004) 0.97
Rapid pulsed-field gel electrophoresis protocol for subtyping of Streptococcus suis serotype 2. J Microbiol Methods (2006) 0.96
Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India. Int J Tuberc Lung Dis (2005) 0.96
Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinb) (2001) 0.96
Utility of polymerase chain reaction using two probes for rapid diagnosis of tubercular pleuritis in comparison to conventional methods. Indian J Med Res (2000) 0.96
Estimation of burden of tuberculosis in India for the year 2000. Indian J Med Res (2005) 0.95
Tuberculin skin test results in HIV-infected patients in India: implications for latent tuberculosis treatment. Int J Tuberc Lung Dis (2008) 0.95
Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J Clin Immunol (2008) 0.94
Comparison of cough of 2 and 3 weeks to improve detection of smear-positive tuberculosis cases among out-patients in India. Int J Tuberc Lung Dis (2005) 0.94
Phage cocktail to control the exponential growth of normal flora in processed sputum specimens grown overnight in liquid medium for rapid TB diagnosis. J Microbiol Methods (2006) 0.94
CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosis. Indian J Med Res (2009) 0.94
Status of smear-positive TB patients at 2-3 years after initiation of treatment under a DOTS programme. Indian J Tuberc (2007) 0.94
Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J Med Res (2000) 0.93
Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2013) 0.93
Streptococcus suis in retail markets: how prevalent is it in raw pork? Int J Food Microbiol (2008) 0.92
Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Int J Antimicrob Agents (2007) 0.92
Evaluation of an intermittent six-month regimen in new pulmonary tuberculosis patients with diabetes mellitus. Indian J Tuberc (2007) 0.92
Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy 'normals'. Int J Tuberc Lung Dis (2004) 0.91
Increased detection by restaining of acid-fast bacilli in sputum samples transported in cetylpyridinium chloride solution. Int J Tuberc Lung Dis (2005) 0.91
Characterization of mycobacterial antigens and antibodies in circulating immune complexes from pulmonary tuberculosis. J Lab Clin Med (1995) 0.91
Implementation of a national anti-tuberculosis drug resistance survey in Tanzania. BMC Public Health (2008) 0.90
Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta (2009) 0.90